医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

New Frontier Healthcare Announces Appointment of Lawrence Chia to Board of Directors

2020年05月22日 PM09:00
このエントリーをはてなブックマークに追加


 

BEIJING

New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (UFH), today announced that Mr. Lawrence Chia has been appointed an independent director of the Company’s board of directors (the “Board”), effective March 31, 2020.

Mr. Lawrence Chia is currently the CEO of the Samling Group of Companies, which has businesses in automobiles, properties, timber, infrastructure, oil palm, oil, and gas, with operations in a number of countries globally. Prior to joining Samling, Lawrence was previously the CEO of Deloitte China, and was on the Deloitte Touche Tohmatsu Limited (DTTL) Executive Committee based in New York and the DTTL Asia Pacific Executive Committee based in Hong Kong. He also serves as an Independent Non-Executive Director of BC Technology Group Limited, a publicly listed company on the Hong Kong Stock Exchange. Mr. Lawrence is a Chartered Accountant of the Institute of Chartered Accountants in England and Wales and a member of the Hong Kong Institute of Certified Public Accountants.

“On behalf of the Board, I am delighted to welcome Lawrence to the team. His more than 30 years of executive leadership experience in financial advisory and corporate finance in Asia will be a great asset to the continued growth of NFH,” said Mr. Antony Leung, Chairman of NFH. “Furthermore, his appointment reflects our commitment to ensuring that we have a broad mix of skills and perspectives on NFH’s board. We look forward to benefiting from his expertise as we continue to make progress on our long-term strategic growth.”

About New Frontier Health Corporation

New Frontier Health Corporation (NYSE: NFH) is the operator of United Family Healthcare (UFH), a leading private healthcare provider offering comprehensive premium healthcare services in China through a network of private hospitals and affiliated ambulatory clinics. UFH currently has nine hospitals in operation or under construction in all four 1st tier cities and selected 2nd tier cities. Additional information may be found at www.nfh.com.cn.

Source: New Frontier Health Corporation

View source version on businesswire.com: https://www.businesswire.com/news/home/20200522005075/en/

CONTACT

Media

Wenjing Liu

Tel: +86-186-1151-5796

Email: liu.wenjing@ufh.com.cn

Investors

Harry Chang

Tel: +852-9822-1806

Email: harry@new-frontier.com

ICR, LLC

William Zima / Rose Zu

Tel: +1-203-682-8200

Email: bill.zima@icrinc.com / rose.zu@icrinc.com

同じカテゴリーの記事 

  • 卫材启用Medidata Clinical Data Studio推进临床试验效率和患者体验的革新
  • Fujirebio推出研究专用全自动Lumipulse®G GFAP检测试剂盒并进一步强化该公司的神经病学产品阵容
  • Fujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu
  • Pearl、歯科AIで史上最大5,800万ドルの資金調達ラウンドを実施
  • FIGS Announces Date of Second Quarter 2024 Earnings Release, Conference Call and Webcast